MEGAN GERWITZ: Open Payments
NPI 1609632926 · KENMORE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,721 in 52 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $832 · 2025 $1,721
Food & beverage: $1,676Education: $45
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $570 |
| AstraZeneca Pharmaceuticals LP | 7 | $366 |
| ACADIA Pharmaceuticals Inc | 1 | $125 |
| Corcept Therapeutics | 6 | $114 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
| Lilly USA, LLC | 1 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
Products named: OTEZLA, BREZTRI, REPATHA, NUPLAZID, Korlym, KRYSTEXXA, AIRSUPRA, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
